Hasani-Ranjbar S, Hoseini Tavassol Z, Malmir H, Ejtahed H, Tajabadi Ebrahimi M, Larijani B
J Diabetes Metab Disord. 2024; 23(1):1141-1149.
PMID: 38932862
PMC: 11196508.
DOI: 10.1007/s40200-024-01400-y.
Kober A, Saha S, Ayyash M, Namai F, Nishiyama K, Yoda K
Nutrients. 2024; 16(9).
PMID: 38732619
PMC: 11085650.
DOI: 10.3390/nu16091373.
Alsharairi N
Nutrients. 2021; 13(11).
PMID: 34835958
PMC: 8624546.
DOI: 10.3390/nu13113702.
Lu W, Deng Y, Fang Z, Zhai Q, Cui S, Zhao J
Nutrients. 2021; 13(6).
PMID: 34207960
PMC: 8230682.
DOI: 10.3390/nu13062010.
Zommiti M, Feuilloley M, Connil N
Microorganisms. 2020; 8(12).
PMID: 33266303
PMC: 7760123.
DOI: 10.3390/microorganisms8121907.
Probiotics for the Treatment of Overweight and Obesity in Humans-A Review of Clinical Trials.
Wicinski M, Gebalski J, Golebiewski J, Malinowski B
Microorganisms. 2020; 8(8).
PMID: 32751306
PMC: 7465252.
DOI: 10.3390/microorganisms8081148.
Cigarette smoking and oral microbiota in low-income and African-American populations.
Yang Y, Zheng W, Cai Q, Shrubsole M, Pei Z, Brucker R
J Epidemiol Community Health. 2019; 73(12):1108-1115.
PMID: 31563898
PMC: 6913090.
DOI: 10.1136/jech-2019-212474.
Oral microbiome and obesity in a large study of low-income and African-American populations.
Yang Y, Cai Q, Zheng W, Steinwandel M, Blot W, Shu X
J Oral Microbiol. 2019; 11(1):1650597.
PMID: 31489128
PMC: 6713186.
DOI: 10.1080/20002297.2019.1650597.
Obesity and asthma: risk, control and treatment.
Marko M, Pawliczak R
Postepy Dermatol Alergol. 2019; 35(6):563-571.
PMID: 30618522
PMC: 6320490.
DOI: 10.5114/ada.2018.77607.
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health.
Markowiak P, Slizewska K
Nutrients. 2017; 9(9).
PMID: 28914794
PMC: 5622781.
DOI: 10.3390/nu9091021.
Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes.
Williamson C, Burns C, Gossard C, Pizano J, Dolan K, Finley H
Integr Med (Encinitas). 2017; 16(1):30-41.
PMID: 28223906
PMC: 5312743.
Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials.
Saez-Lara M, Robles-Sanchez C, Ruiz-Ojeda F, Plaza-Diaz J, Gil A
Int J Mol Sci. 2016; 17(6).
PMID: 27304953
PMC: 4926461.
DOI: 10.3390/ijms17060928.
